Posted by Michael Wonder on 02 Sep 2022
FDA approves the first treatment option for generalized pustular psoriasis flares in adults
1 September 2022 - More than half of patients treated with Spevigo (spesolimab-sbzo) injection, for intravenous use showed no visible pustules one week after receiving treatment.
Boehringer Ingelheim announced today the US FDA has approved Sprevigo, the first approved treatment option for generalised pustular psoriasis flares in adults.
